nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—ABCB1—Methylprednisolone—psoriatic arthritis	0.0821	0.118	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0636	0.0913	CbGbCtD
Temsirolimus—CYP3A7—Dexamethasone—psoriatic arthritis	0.0636	0.0913	CbGbCtD
Temsirolimus—ABCB1—Betamethasone—psoriatic arthritis	0.0534	0.0766	CbGbCtD
Temsirolimus—ABCB1—Prednisolone—psoriatic arthritis	0.0527	0.0756	CbGbCtD
Temsirolimus—ABCB1—Prednisone—psoriatic arthritis	0.0497	0.0714	CbGbCtD
Temsirolimus—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0492	0.0706	CbGbCtD
Temsirolimus—CYP3A5—Dexamethasone—psoriatic arthritis	0.0477	0.0685	CbGbCtD
Temsirolimus—CYP3A4—Triamcinolone—psoriatic arthritis	0.0373	0.0535	CbGbCtD
Temsirolimus—CYP3A4—Betamethasone—psoriatic arthritis	0.032	0.0459	CbGbCtD
Temsirolimus—CYP3A4—Prednisolone—psoriatic arthritis	0.0316	0.0453	CbGbCtD
Temsirolimus—ABCB1—Dexamethasone—psoriatic arthritis	0.0311	0.0446	CbGbCtD
Temsirolimus—CYP3A4—Prednisone—psoriatic arthritis	0.0298	0.0428	CbGbCtD
Temsirolimus—CYP2D6—Dexamethasone—psoriatic arthritis	0.0293	0.042	CbGbCtD
Temsirolimus—ABCB1—Methotrexate—psoriatic arthritis	0.025	0.0358	CbGbCtD
Temsirolimus—CYP3A4—Dexamethasone—psoriatic arthritis	0.0186	0.0267	CbGbCtD
Temsirolimus—Rhinitis—Methylprednisolone—psoriatic arthritis	0.000488	0.00161	CcSEcCtD
Temsirolimus—Abdominal distension—Prednisone—psoriatic arthritis	0.000484	0.0016	CcSEcCtD
Temsirolimus—Pharyngitis—Triamcinolone—psoriatic arthritis	0.000484	0.00159	CcSEcCtD
Temsirolimus—Conjunctivitis—Dexamethasone—psoriatic arthritis	0.000479	0.00158	CcSEcCtD
Temsirolimus—Conjunctivitis—Betamethasone—psoriatic arthritis	0.000479	0.00158	CcSEcCtD
Temsirolimus—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.000478	0.00158	CcSEcCtD
Temsirolimus—Erythema—Prednisolone—psoriatic arthritis	0.000461	0.00152	CcSEcCtD
Temsirolimus—Eye disorder—Methylprednisolone—psoriatic arthritis	0.000455	0.0015	CcSEcCtD
Temsirolimus—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.000451	0.00149	CcSEcCtD
Temsirolimus—Neutropenia—Prednisone—psoriatic arthritis	0.00045	0.00148	CcSEcCtD
Temsirolimus—Angiopathy—Methylprednisolone—psoriatic arthritis	0.000441	0.00145	CcSEcCtD
Temsirolimus—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.000439	0.00145	CcSEcCtD
Temsirolimus—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.000438	0.00145	CcSEcCtD
Temsirolimus—Weight decreased—Prednisone—psoriatic arthritis	0.000435	0.00144	CcSEcCtD
Temsirolimus—Hyperglycaemia—Prednisone—psoriatic arthritis	0.000434	0.00143	CcSEcCtD
Temsirolimus—Depression—Prednisone—psoriatic arthritis	0.000428	0.00141	CcSEcCtD
Temsirolimus—Mental disorder—Methylprednisolone—psoriatic arthritis	0.000426	0.0014	CcSEcCtD
Temsirolimus—Erythema—Triamcinolone—psoriatic arthritis	0.000424	0.0014	CcSEcCtD
Temsirolimus—Erythema—Methylprednisolone—psoriatic arthritis	0.000423	0.0014	CcSEcCtD
Temsirolimus—Malnutrition—Methylprednisolone—psoriatic arthritis	0.000423	0.0014	CcSEcCtD
Temsirolimus—Angioedema—Prednisolone—psoriatic arthritis	0.000422	0.00139	CcSEcCtD
Temsirolimus—Dysgeusia—Triamcinolone—psoriatic arthritis	0.000416	0.00137	CcSEcCtD
Temsirolimus—Eye disorder—Betamethasone—psoriatic arthritis	0.000413	0.00136	CcSEcCtD
Temsirolimus—Eye disorder—Dexamethasone—psoriatic arthritis	0.000413	0.00136	CcSEcCtD
Temsirolimus—Back pain—Triamcinolone—psoriatic arthritis	0.00041	0.00135	CcSEcCtD
Temsirolimus—Angiopathy—Betamethasone—psoriatic arthritis	0.000401	0.00132	CcSEcCtD
Temsirolimus—Angiopathy—Dexamethasone—psoriatic arthritis	0.000401	0.00132	CcSEcCtD
Temsirolimus—Convulsion—Prednisolone—psoriatic arthritis	0.0004	0.00132	CcSEcCtD
Temsirolimus—Hypertension—Prednisolone—psoriatic arthritis	0.000398	0.00131	CcSEcCtD
Temsirolimus—Angioedema—Triamcinolone—psoriatic arthritis	0.000388	0.00128	CcSEcCtD
Temsirolimus—Angioedema—Methylprednisolone—psoriatic arthritis	0.000387	0.00128	CcSEcCtD
Temsirolimus—Erythema—Dexamethasone—psoriatic arthritis	0.000385	0.00127	CcSEcCtD
Temsirolimus—Erythema—Betamethasone—psoriatic arthritis	0.000385	0.00127	CcSEcCtD
Temsirolimus—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000379	0.00125	CcSEcCtD
Temsirolimus—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000377	0.00124	CcSEcCtD
Temsirolimus—Oedema—Prednisolone—psoriatic arthritis	0.000377	0.00124	CcSEcCtD
Temsirolimus—Dysuria—Methotrexate—psoriatic arthritis	0.000376	0.00124	CcSEcCtD
Temsirolimus—Neutropenia—Methotrexate—psoriatic arthritis	0.000376	0.00124	CcSEcCtD
Temsirolimus—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.000374	0.00123	CcSEcCtD
Temsirolimus—Cough—Triamcinolone—psoriatic arthritis	0.00037	0.00122	CcSEcCtD
Temsirolimus—Convulsion—Triamcinolone—psoriatic arthritis	0.000368	0.00121	CcSEcCtD
Temsirolimus—Convulsion—Methylprednisolone—psoriatic arthritis	0.000367	0.00121	CcSEcCtD
Temsirolimus—Hypertension—Triamcinolone—psoriatic arthritis	0.000366	0.00121	CcSEcCtD
Temsirolimus—Hypertension—Methylprednisolone—psoriatic arthritis	0.000366	0.00121	CcSEcCtD
Temsirolimus—Myalgia—Triamcinolone—psoriatic arthritis	0.000361	0.00119	CcSEcCtD
Temsirolimus—Pneumonia—Methotrexate—psoriatic arthritis	0.000361	0.00119	CcSEcCtD
Temsirolimus—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00036	0.00119	CcSEcCtD
Temsirolimus—Myalgia—Methylprednisolone—psoriatic arthritis	0.00036	0.00119	CcSEcCtD
Temsirolimus—Eye disorder—Prednisone—psoriatic arthritis	0.00036	0.00119	CcSEcCtD
Temsirolimus—Anxiety—Methylprednisolone—psoriatic arthritis	0.000359	0.00118	CcSEcCtD
Temsirolimus—Infestation NOS—Methotrexate—psoriatic arthritis	0.000359	0.00118	CcSEcCtD
Temsirolimus—Infestation—Methotrexate—psoriatic arthritis	0.000359	0.00118	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000358	0.00118	CcSEcCtD
Temsirolimus—Depression—Methotrexate—psoriatic arthritis	0.000358	0.00118	CcSEcCtD
Temsirolimus—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000356	0.00117	CcSEcCtD
Temsirolimus—Renal failure—Methotrexate—psoriatic arthritis	0.000352	0.00116	CcSEcCtD
Temsirolimus—Angioedema—Dexamethasone—psoriatic arthritis	0.000352	0.00116	CcSEcCtD
Temsirolimus—Angioedema—Betamethasone—psoriatic arthritis	0.000352	0.00116	CcSEcCtD
Temsirolimus—Stomatitis—Methotrexate—psoriatic arthritis	0.00035	0.00115	CcSEcCtD
Temsirolimus—Angiopathy—Prednisone—psoriatic arthritis	0.000349	0.00115	CcSEcCtD
Temsirolimus—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000349	0.00115	CcSEcCtD
Temsirolimus—Immune system disorder—Prednisone—psoriatic arthritis	0.000348	0.00115	CcSEcCtD
Temsirolimus—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000346	0.00114	CcSEcCtD
Temsirolimus—Oedema—Triamcinolone—psoriatic arthritis	0.000346	0.00114	CcSEcCtD
Temsirolimus—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000346	0.00114	CcSEcCtD
Temsirolimus—Infection—Triamcinolone—psoriatic arthritis	0.000344	0.00113	CcSEcCtD
Temsirolimus—Infection—Methylprednisolone—psoriatic arthritis	0.000343	0.00113	CcSEcCtD
Temsirolimus—Haematuria—Methotrexate—psoriatic arthritis	0.000342	0.00113	CcSEcCtD
Temsirolimus—Insomnia—Prednisolone—psoriatic arthritis	0.000341	0.00112	CcSEcCtD
Temsirolimus—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000339	0.00112	CcSEcCtD
Temsirolimus—Epistaxis—Methotrexate—psoriatic arthritis	0.000338	0.00112	CcSEcCtD
Temsirolimus—Mental disorder—Prednisone—psoriatic arthritis	0.000337	0.00111	CcSEcCtD
Temsirolimus—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000336	0.00111	CcSEcCtD
Temsirolimus—Malnutrition—Prednisone—psoriatic arthritis	0.000335	0.00111	CcSEcCtD
Temsirolimus—Erythema—Prednisone—psoriatic arthritis	0.000335	0.00111	CcSEcCtD
Temsirolimus—Convulsion—Dexamethasone—psoriatic arthritis	0.000334	0.0011	CcSEcCtD
Temsirolimus—Convulsion—Betamethasone—psoriatic arthritis	0.000334	0.0011	CcSEcCtD
Temsirolimus—Hypertension—Dexamethasone—psoriatic arthritis	0.000332	0.0011	CcSEcCtD
Temsirolimus—Hypertension—Betamethasone—psoriatic arthritis	0.000332	0.0011	CcSEcCtD
Temsirolimus—Myalgia—Betamethasone—psoriatic arthritis	0.000328	0.00108	CcSEcCtD
Temsirolimus—Myalgia—Dexamethasone—psoriatic arthritis	0.000328	0.00108	CcSEcCtD
Temsirolimus—Anxiety—Betamethasone—psoriatic arthritis	0.000327	0.00108	CcSEcCtD
Temsirolimus—Anxiety—Dexamethasone—psoriatic arthritis	0.000327	0.00108	CcSEcCtD
Temsirolimus—Pain—Prednisolone—psoriatic arthritis	0.000322	0.00106	CcSEcCtD
Temsirolimus—Pharyngitis—Methotrexate—psoriatic arthritis	0.000319	0.00105	CcSEcCtD
Temsirolimus—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000318	0.00105	CcSEcCtD
Temsirolimus—Urethral disorder—Methotrexate—psoriatic arthritis	0.000316	0.00104	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000316	0.00104	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000315	0.00104	CcSEcCtD
Temsirolimus—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000314	0.00104	CcSEcCtD
Temsirolimus—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000314	0.00104	CcSEcCtD
Temsirolimus—Oedema—Dexamethasone—psoriatic arthritis	0.000314	0.00104	CcSEcCtD
Temsirolimus—Oedema—Betamethasone—psoriatic arthritis	0.000314	0.00104	CcSEcCtD
Temsirolimus—Insomnia—Triamcinolone—psoriatic arthritis	0.000313	0.00103	CcSEcCtD
Temsirolimus—Insomnia—Methylprednisolone—psoriatic arthritis	0.000313	0.00103	CcSEcCtD
Temsirolimus—Infection—Betamethasone—psoriatic arthritis	0.000312	0.00103	CcSEcCtD
Temsirolimus—Infection—Dexamethasone—psoriatic arthritis	0.000312	0.00103	CcSEcCtD
Temsirolimus—Anaemia—Prednisone—psoriatic arthritis	0.00031	0.00102	CcSEcCtD
Temsirolimus—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000309	0.00102	CcSEcCtD
Temsirolimus—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000308	0.00102	CcSEcCtD
Temsirolimus—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000308	0.00102	CcSEcCtD
Temsirolimus—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000308	0.00101	CcSEcCtD
Temsirolimus—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000308	0.00101	CcSEcCtD
Temsirolimus—Angioedema—Prednisone—psoriatic arthritis	0.000306	0.00101	CcSEcCtD
Temsirolimus—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000304	0.001	CcSEcCtD
Temsirolimus—Eye disorder—Methotrexate—psoriatic arthritis	0.000301	0.000992	CcSEcCtD
Temsirolimus—Anorexia—Dexamethasone—psoriatic arthritis	0.0003	0.000987	CcSEcCtD
Temsirolimus—Anorexia—Betamethasone—psoriatic arthritis	0.0003	0.000987	CcSEcCtD
Temsirolimus—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000299	0.000985	CcSEcCtD
Temsirolimus—Fatigue—Triamcinolone—psoriatic arthritis	0.000299	0.000984	CcSEcCtD
Temsirolimus—Fatigue—Methylprednisolone—psoriatic arthritis	0.000298	0.000982	CcSEcCtD
Temsirolimus—Pain—Triamcinolone—psoriatic arthritis	0.000296	0.000976	CcSEcCtD
Temsirolimus—Angiopathy—Methotrexate—psoriatic arthritis	0.000292	0.000963	CcSEcCtD
Temsirolimus—Immune system disorder—Methotrexate—psoriatic arthritis	0.000291	0.000959	CcSEcCtD
Temsirolimus—Convulsion—Prednisone—psoriatic arthritis	0.000291	0.000958	CcSEcCtD
Temsirolimus—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00029	0.000956	CcSEcCtD
Temsirolimus—Hypertension—Prednisone—psoriatic arthritis	0.000289	0.000954	CcSEcCtD
Temsirolimus—Chills—Methotrexate—psoriatic arthritis	0.000289	0.000952	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000286	0.000944	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000286	0.000944	CcSEcCtD
Temsirolimus—Arthralgia—Prednisone—psoriatic arthritis	0.000285	0.000941	CcSEcCtD
Temsirolimus—Myalgia—Prednisone—psoriatic arthritis	0.000285	0.000941	CcSEcCtD
Temsirolimus—Anxiety—Prednisone—psoriatic arthritis	0.000284	0.000938	CcSEcCtD
Temsirolimus—Insomnia—Betamethasone—psoriatic arthritis	0.000284	0.000937	CcSEcCtD
Temsirolimus—Insomnia—Dexamethasone—psoriatic arthritis	0.000284	0.000937	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000284	0.000935	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000283	0.000932	CcSEcCtD
Temsirolimus—Mental disorder—Methotrexate—psoriatic arthritis	0.000282	0.00093	CcSEcCtD
Temsirolimus—Malnutrition—Methotrexate—psoriatic arthritis	0.00028	0.000924	CcSEcCtD
Temsirolimus—Erythema—Methotrexate—psoriatic arthritis	0.00028	0.000924	CcSEcCtD
Temsirolimus—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000277	0.000915	CcSEcCtD
Temsirolimus—Dysgeusia—Methotrexate—psoriatic arthritis	0.000274	0.000905	CcSEcCtD
Temsirolimus—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000274	0.000903	CcSEcCtD
Temsirolimus—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000274	0.000902	CcSEcCtD
Temsirolimus—Oedema—Prednisone—psoriatic arthritis	0.000274	0.000902	CcSEcCtD
Temsirolimus—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000273	0.000901	CcSEcCtD
Temsirolimus—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000273	0.000901	CcSEcCtD
Temsirolimus—Decreased appetite—Betamethasone—psoriatic arthritis	0.000273	0.000901	CcSEcCtD
Temsirolimus—Infection—Prednisone—psoriatic arthritis	0.000272	0.000896	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000271	0.000894	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000271	0.000894	CcSEcCtD
Temsirolimus—Back pain—Methotrexate—psoriatic arthritis	0.000271	0.000894	CcSEcCtD
Temsirolimus—Fatigue—Betamethasone—psoriatic arthritis	0.000271	0.000893	CcSEcCtD
Temsirolimus—Fatigue—Dexamethasone—psoriatic arthritis	0.000271	0.000893	CcSEcCtD
Temsirolimus—Pain—Dexamethasone—psoriatic arthritis	0.000269	0.000886	CcSEcCtD
Temsirolimus—Pain—Betamethasone—psoriatic arthritis	0.000269	0.000886	CcSEcCtD
Temsirolimus—Nervous system disorder—Prednisone—psoriatic arthritis	0.000268	0.000885	CcSEcCtD
Temsirolimus—Skin disorder—Prednisone—psoriatic arthritis	0.000266	0.000876	CcSEcCtD
Temsirolimus—Anorexia—Prednisone—psoriatic arthritis	0.000261	0.00086	CcSEcCtD
Temsirolimus—Anaemia—Methotrexate—psoriatic arthritis	0.000259	0.000854	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000257	0.000847	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000257	0.000847	CcSEcCtD
Temsirolimus—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000255	0.000841	CcSEcCtD
Temsirolimus—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000255	0.000839	CcSEcCtD
Temsirolimus—Leukopenia—Methotrexate—psoriatic arthritis	0.000251	0.000827	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000249	0.000822	CcSEcCtD
Temsirolimus—Dizziness—Prednisolone—psoriatic arthritis	0.000249	0.000821	CcSEcCtD
Temsirolimus—Asthenia—Triamcinolone—psoriatic arthritis	0.000248	0.000819	CcSEcCtD
Temsirolimus—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000248	0.000819	CcSEcCtD
Temsirolimus—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000248	0.000819	CcSEcCtD
Temsirolimus—Abdominal pain—Betamethasone—psoriatic arthritis	0.000248	0.000819	CcSEcCtD
Temsirolimus—Body temperature increased—Betamethasone—psoriatic arthritis	0.000248	0.000819	CcSEcCtD
Temsirolimus—Asthenia—Methylprednisolone—psoriatic arthritis	0.000248	0.000817	CcSEcCtD
Temsirolimus—Insomnia—Prednisone—psoriatic arthritis	0.000248	0.000816	CcSEcCtD
Temsirolimus—Pruritus—Triamcinolone—psoriatic arthritis	0.000245	0.000808	CcSEcCtD
Temsirolimus—Cough—Methotrexate—psoriatic arthritis	0.000245	0.000806	CcSEcCtD
Temsirolimus—Pruritus—Methylprednisolone—psoriatic arthritis	0.000244	0.000806	CcSEcCtD
Temsirolimus—Convulsion—Methotrexate—psoriatic arthritis	0.000243	0.0008	CcSEcCtD
Temsirolimus—Chest pain—Methotrexate—psoriatic arthritis	0.000239	0.000786	CcSEcCtD
Temsirolimus—Arthralgia—Methotrexate—psoriatic arthritis	0.000239	0.000786	CcSEcCtD
Temsirolimus—Myalgia—Methotrexate—psoriatic arthritis	0.000239	0.000786	CcSEcCtD
Temsirolimus—Decreased appetite—Prednisone—psoriatic arthritis	0.000238	0.000784	CcSEcCtD
Temsirolimus—Rash—Prednisolone—psoriatic arthritis	0.000237	0.000783	CcSEcCtD
Temsirolimus—Dermatitis—Prednisolone—psoriatic arthritis	0.000237	0.000782	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000237	0.000781	CcSEcCtD
Temsirolimus—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000236	0.000779	CcSEcCtD
Temsirolimus—Fatigue—Prednisone—psoriatic arthritis	0.000236	0.000778	CcSEcCtD
Temsirolimus—Headache—Prednisolone—psoriatic arthritis	0.000236	0.000778	CcSEcCtD
Temsirolimus—Constipation—Prednisone—psoriatic arthritis	0.000234	0.000771	CcSEcCtD
Temsirolimus—Dizziness—Triamcinolone—psoriatic arthritis	0.000229	0.000755	CcSEcCtD
Temsirolimus—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000229	0.000754	CcSEcCtD
Temsirolimus—Dizziness—Methylprednisolone—psoriatic arthritis	0.000229	0.000753	CcSEcCtD
Temsirolimus—Infection—Methotrexate—psoriatic arthritis	0.000227	0.000749	CcSEcCtD
Temsirolimus—Asthenia—Betamethasone—psoriatic arthritis	0.000225	0.000743	CcSEcCtD
Temsirolimus—Asthenia—Dexamethasone—psoriatic arthritis	0.000225	0.000743	CcSEcCtD
Temsirolimus—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000224	0.000739	CcSEcCtD
Temsirolimus—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000224	0.000738	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000224	0.000738	CcSEcCtD
Temsirolimus—Nausea—Prednisolone—psoriatic arthritis	0.000224	0.000737	CcSEcCtD
Temsirolimus—Pruritus—Betamethasone—psoriatic arthritis	0.000222	0.000733	CcSEcCtD
Temsirolimus—Pruritus—Dexamethasone—psoriatic arthritis	0.000222	0.000733	CcSEcCtD
Temsirolimus—Skin disorder—Methotrexate—psoriatic arthritis	0.000222	0.000732	CcSEcCtD
Temsirolimus—Vomiting—Triamcinolone—psoriatic arthritis	0.00022	0.000726	CcSEcCtD
Temsirolimus—Vomiting—Methylprednisolone—psoriatic arthritis	0.00022	0.000724	CcSEcCtD
Temsirolimus—Rash—Triamcinolone—psoriatic arthritis	0.000218	0.00072	CcSEcCtD
Temsirolimus—Dermatitis—Triamcinolone—psoriatic arthritis	0.000218	0.000719	CcSEcCtD
Temsirolimus—Anorexia—Methotrexate—psoriatic arthritis	0.000218	0.000719	CcSEcCtD
Temsirolimus—Rash—Methylprednisolone—psoriatic arthritis	0.000218	0.000718	CcSEcCtD
Temsirolimus—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000218	0.000718	CcSEcCtD
Temsirolimus—Headache—Triamcinolone—psoriatic arthritis	0.000217	0.000715	CcSEcCtD
Temsirolimus—Headache—Methylprednisolone—psoriatic arthritis	0.000216	0.000714	CcSEcCtD
Temsirolimus—Body temperature increased—Prednisone—psoriatic arthritis	0.000216	0.000713	CcSEcCtD
Temsirolimus—Abdominal pain—Prednisone—psoriatic arthritis	0.000216	0.000713	CcSEcCtD
Temsirolimus—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000215	0.000709	CcSEcCtD
Temsirolimus—Diarrhoea—Betamethasone—psoriatic arthritis	0.000215	0.000709	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000208	0.000687	CcSEcCtD
Temsirolimus—Dizziness—Dexamethasone—psoriatic arthritis	0.000208	0.000685	CcSEcCtD
Temsirolimus—Dizziness—Betamethasone—psoriatic arthritis	0.000208	0.000685	CcSEcCtD
Temsirolimus—Insomnia—Methotrexate—psoriatic arthritis	0.000207	0.000682	CcSEcCtD
Temsirolimus—Nausea—Triamcinolone—psoriatic arthritis	0.000206	0.000678	CcSEcCtD
Temsirolimus—Nausea—Methylprednisolone—psoriatic arthritis	0.000205	0.000677	CcSEcCtD
Temsirolimus—Dyspnoea—Methotrexate—psoriatic arthritis	0.000204	0.000672	CcSEcCtD
Temsirolimus—Somnolence—Methotrexate—psoriatic arthritis	0.000203	0.00067	CcSEcCtD
Temsirolimus—Hypersensitivity—Prednisone—psoriatic arthritis	0.000202	0.000665	CcSEcCtD
Temsirolimus—Vomiting—Dexamethasone—psoriatic arthritis	0.0002	0.000659	CcSEcCtD
Temsirolimus—Vomiting—Betamethasone—psoriatic arthritis	0.0002	0.000659	CcSEcCtD
Temsirolimus—Decreased appetite—Methotrexate—psoriatic arthritis	0.000199	0.000655	CcSEcCtD
Temsirolimus—Rash—Dexamethasone—psoriatic arthritis	0.000198	0.000653	CcSEcCtD
Temsirolimus—Rash—Betamethasone—psoriatic arthritis	0.000198	0.000653	CcSEcCtD
Temsirolimus—Dermatitis—Betamethasone—psoriatic arthritis	0.000198	0.000653	CcSEcCtD
Temsirolimus—Dermatitis—Dexamethasone—psoriatic arthritis	0.000198	0.000653	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000197	0.000651	CcSEcCtD
Temsirolimus—Fatigue—Methotrexate—psoriatic arthritis	0.000197	0.00065	CcSEcCtD
Temsirolimus—Headache—Dexamethasone—psoriatic arthritis	0.000197	0.000649	CcSEcCtD
Temsirolimus—Headache—Betamethasone—psoriatic arthritis	0.000197	0.000649	CcSEcCtD
Temsirolimus—Asthenia—Prednisone—psoriatic arthritis	0.000196	0.000647	CcSEcCtD
Temsirolimus—Pain—Methotrexate—psoriatic arthritis	0.000196	0.000645	CcSEcCtD
Temsirolimus—Pruritus—Prednisone—psoriatic arthritis	0.000194	0.000638	CcSEcCtD
Temsirolimus—Diarrhoea—Prednisone—psoriatic arthritis	0.000187	0.000617	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000187	0.000617	CcSEcCtD
Temsirolimus—Nausea—Dexamethasone—psoriatic arthritis	0.000187	0.000615	CcSEcCtD
Temsirolimus—Nausea—Betamethasone—psoriatic arthritis	0.000187	0.000615	CcSEcCtD
Temsirolimus—Dizziness—Prednisone—psoriatic arthritis	0.000181	0.000597	CcSEcCtD
Temsirolimus—Body temperature increased—Methotrexate—psoriatic arthritis	0.000181	0.000596	CcSEcCtD
Temsirolimus—Abdominal pain—Methotrexate—psoriatic arthritis	0.000181	0.000596	CcSEcCtD
Temsirolimus—Vomiting—Prednisone—psoriatic arthritis	0.000174	0.000574	CcSEcCtD
Temsirolimus—Rash—Prednisone—psoriatic arthritis	0.000173	0.000569	CcSEcCtD
Temsirolimus—Dermatitis—Prednisone—psoriatic arthritis	0.000172	0.000568	CcSEcCtD
Temsirolimus—Headache—Prednisone—psoriatic arthritis	0.000171	0.000565	CcSEcCtD
Temsirolimus—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000168	0.000555	CcSEcCtD
Temsirolimus—Asthenia—Methotrexate—psoriatic arthritis	0.000164	0.000541	CcSEcCtD
Temsirolimus—Nausea—Prednisone—psoriatic arthritis	0.000163	0.000536	CcSEcCtD
Temsirolimus—Pruritus—Methotrexate—psoriatic arthritis	0.000162	0.000533	CcSEcCtD
Temsirolimus—Diarrhoea—Methotrexate—psoriatic arthritis	0.000156	0.000516	CcSEcCtD
Temsirolimus—Dizziness—Methotrexate—psoriatic arthritis	0.000151	0.000499	CcSEcCtD
Temsirolimus—Vomiting—Methotrexate—psoriatic arthritis	0.000145	0.000479	CcSEcCtD
Temsirolimus—Rash—Methotrexate—psoriatic arthritis	0.000144	0.000475	CcSEcCtD
Temsirolimus—Dermatitis—Methotrexate—psoriatic arthritis	0.000144	0.000475	CcSEcCtD
Temsirolimus—Headache—Methotrexate—psoriatic arthritis	0.000143	0.000472	CcSEcCtD
Temsirolimus—Nausea—Methotrexate—psoriatic arthritis	0.000136	0.000448	CcSEcCtD
